Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Targanta Therapeutics Corporation
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Complicated skin and skin structure infection, presumed or proven to be caused by gram-positive pathogen(s).
Patients, ages 18 years and older, must not be below normal body weight or morbidly obese.
Female patients must not be pregnant at time of enrollment and must agree to a reliable method of birth control during the study and for 6 months following the last dose of study drug.
You may not be if
Patients:
with a condition which would prevent performing protocol safety and efficacy assessments.
who have received antibiotics for more than 24 hours within the last 3 days.
with an infection involving deep tissues or unlikely to be caused by gram positive bacteria
who are nursing and will not stop nursing for at least 6 months
with a prior allergic reaction to glycopeptides (e.g. vancomycin)
with any of the following:
1. toxic shock syndrome or toxic-like syndrome
2. presumed or proven infection caused by Clostridium species
3. bone infections
4. ischemic or gangrenous ulcers or wounds
5. infections caused only by gram-negative bacteria
6. infection of an artificial joint that cannot be removed
7. infection of the scrotum, perineum or perianal region
8. infection of a severe burn wound
9. severe ear infection involving bone and/or cartilage
10. infection following injury in water possibly containing Vibrio species or following a history of eating raw oysters within 1 week prior to disease onset
Clareo Health | A Study for Patients With Complicated Skin and Skin Structure Infections
